Publication | Open Access
Adverse Effects of Diabetes Mellitus on the Skeleton of Aging Mice
13
Citations
36
References
2015
Year
Old Mouse BoneAgingAging MiceBone VolumeBiogerontologyOrthopaedic SurgeryOsteoporosisInsulin SignalingObesityMetabolic SyndromeLongevityAdverse EffectsBone TurnoverBone HomeostasisHealth SciencesBone HealthSkeletal BiologyDiabetes ComplicationsEndocrinologyBone MetabolismDiabetesPhysiologyDiabetes MellitusMusculoskeletal AgingMetabolic Bone DiseaseMedicine
In the present study, the possibility that a diabetic (DM) status might worsen age-related bone deterioration was explored in mice. Male CD-1 mice aged 2 (young control group) or 16 months, nondiabetic or made diabetic by streptozotocin injections, were used. DM induced a decrease in bone volume, trabecular number, and eroded surface, and in mineral apposition and bone formation rates, but an increased trabecular separation, in L1-L3 vertebrae of aged mice. Three-point bending and reference point indentation tests showed slight changes pointing to increased frailty and brittleness in the mouse tibia of diabetic old mice. DM was related to a decreased expression of both vascular endothelial growth factor and its receptor 2, which paralleled that of femoral vasculature, and increased expression of the pro-adipogenic gene peroxisome proliferator-activated receptor γ and adipocyte number, without affecting β-catenin pathway in old mouse bone. Concomitant DM in old mice failed to affect total glutathione levels or activity of main anti-oxidative stress enzymes, although xanthine oxidase was slightly increased, in the bone marrow, but increased the senescence marker caveolin-1 gene. In conclusion, DM worsens bone alterations of aged mice, related to decreased bone turnover and bone vasculature and increased senescence, independently of the anti-oxidative stress machinery.
| Year | Citations | |
|---|---|---|
Page 1
Page 1